Cologne Cohort of Neutropenic Patients (CoCoNut)

The Cologne Cohort of Neutropenic Patients (CoCoNut) - a Non-interventional Cohort Study Assessing Risk Factors, Interventions, and Outcome of Immunosuppressed Patients With or Without Opportunistic Infections

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01821456

Acronym

CoCoNut

Enrollment

100000

Registered

2013-04-01

Start date

1995-01-31

Completion date

2050-12-31

Last updated

2013-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Chemotherapy, Hematological Malignancies, Immunosuppression, Neutropenia

Keywords

hematological malignancies, cancer, chemotherapy, anti-infectives, treatment, outcome

Brief summary

The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.

Detailed description

This prospective cohort was established with the aim of a comprehensive data collection of all patients developing neutropenia after receiving chemotherapy for any kind of malignant disease, treated in the University Hospital of Cologne.

Interventions

DRUGAntiinfectives

To analyze to efficacy of (novel) drug therapies

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* immunosuppressed patients

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
Long-term survival of hematology and oncology patients following neutropenia	2 years following last follow-up

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026